• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

作者信息

Dreyling M, Ghielmini M, Rule S, Salles G, Vitolo U, Ladetto M

机构信息

Department of Medicine III, University of Munich, Germany.

Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.

出版信息

Ann Oncol. 2016 Sep;27(suppl 5):v83-v90. doi: 10.1093/annonc/mdw400.

DOI:10.1093/annonc/mdw400
PMID:27664263
Abstract
摘要

相似文献

1
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发滤泡性淋巴瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v83-v90. doi: 10.1093/annonc/mdw400.
2
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发的滤泡性淋巴瘤：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2011 Sep;22 Suppl 6:vi59-63. doi: 10.1093/annonc/mdr388.
3
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发滤泡性淋巴瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2014 Sep;25 Suppl 3:iii76-82. doi: 10.1093/annonc/mdu200. Epub 2014 Aug 13.
4
Newly diagnosed and relapsed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.新诊断及复发滤泡性淋巴瘤：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii77-8. doi: 10.1093/annonc/mdn096.
5
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发滤泡性淋巴瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Mar;32(3):298-308. doi: 10.1016/j.annonc.2020.11.008. Epub 2020 Nov 26.
6
Newly diagnosed and relapsed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.新诊断及复发滤泡性淋巴瘤：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2009 May;20 Suppl 4:119-20. doi: 10.1093/annonc/mdp148.
7
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发的滤泡性淋巴瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2010 May;21 Suppl 5:v181-3. doi: 10.1093/annonc/mdq184.
8
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma.欧洲肿瘤内科学会（ESMO）关于新诊断滤泡性淋巴瘤诊断、治疗及随访的最低临床建议
Ann Oncol. 2003 Aug;14(8):1163-4. doi: 10.1093/annonc/mdg338.
9
Newly diagnosed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.新诊断的滤泡性淋巴瘤：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2007 Apr;18 Suppl 2:ii63-4. doi: 10.1093/annonc/mdm041.
10
Diagnosis and management of follicular lymphoma: A comprehensive review.滤泡性淋巴瘤的诊断与治疗：全面综述。
Eur J Haematol. 2019 Sep;103(3):152-163. doi: 10.1111/ejh.13271. Epub 2019 Jul 4.

引用本文的文献

1
Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408.结外病变对滤泡性淋巴瘤PET/CT的预后影响：来自ECOG 2408验证研究的结果
Blood Neoplasia. 2025 May 11;2(3):100113. doi: 10.1016/j.bneo.2025.100113. eCollection 2025 Aug.
2
Rethinking bone marrow biopsy: is PET/CT enough for staging low-grade follicular lymphomas?重新审视骨髓活检：PET/CT对于低度滤泡性淋巴瘤分期是否足够？
Ann Hematol. 2025 Jul 17. doi: 10.1007/s00277-025-06487-8.
3
The Usefulness of Mediastinal Cryobiopsy in the Diagnosis of Mediastinal Lymphadenopathy in HIV Patients.
纵隔冷冻活检在HIV患者纵隔淋巴结病诊断中的应用价值
HIV AIDS (Auckl). 2025 Jun 7;17:135-141. doi: 10.2147/HIV.S499971. eCollection 2025.
4
Single-Agent and Associated Therapies with Monoclonal Antibodies: What About Follicular Lymphoma?单克隆抗体的单药治疗及联合疗法：滤泡性淋巴瘤的情况如何？
Cancers (Basel). 2025 May 8;17(10):1602. doi: 10.3390/cancers17101602.
5
Follicular lymphoma grade 3A: aggressiveness and curability in an Asian cohort of 781 patients.滤泡性淋巴瘤3A级：781例亚洲患者队列中的侵袭性与可治愈性
Ann Hematol. 2025 Apr;104(4):2437-2448. doi: 10.1007/s00277-025-06349-3. Epub 2025 Apr 10.
6
A Cost-Effectiveness Analysis of Axicabtagene Ciloleucel versus Tisagenlecleucel in the Treatment of Diffuse Large B-cell Lymphoma Based on a Real-World French Registry.基于真实世界法国登记数据的阿基仑赛与Tisagenlecleucel 治疗弥漫性大 B 细胞淋巴瘤的成本-效果分析。
Adv Ther. 2024 Nov;41(11):4282-4298. doi: 10.1007/s12325-024-02971-1. Epub 2024 Sep 24.
7
Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice.滤泡性淋巴瘤患者在一线、二线和三线治疗后的无进展生存期。
Acta Oncol. 2024 May 6;63:267-272. doi: 10.2340/1651-226X.2024.24377.
8
Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion.利妥昔单抗通过使白血病细胞对 CAR-T 介导的细胞毒性敏感和减少 CAR-T 衰竭，可能改善 r/r B-ALL 患者接受 CAR-T 治疗的临床结局。
Cell Oncol (Dordr). 2024 Oct;47(5):1649-1661. doi: 10.1007/s13402-024-00945-7. Epub 2024 Apr 25.
9
Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study.比较苯达莫司汀与利妥昔单抗联合环磷酰胺、阿霉素、长春新碱和泼尼松（R-CHOP）加维持治疗作为滤泡性淋巴瘤一线全身治疗的疗效：一项多中心回顾性GELTAMO研究
Cancers (Basel). 2024 Mar 26;16(7):1285. doi: 10.3390/cancers16071285.
10
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial.研究者在复发性滤泡性淋巴瘤（REFRACT）治疗中选择标准治疗与序贯新型治疗臂：一项多中心、开放标签、随机、二期平台试验的研究方案。
BMC Cancer. 2024 Mar 25;24(1):370. doi: 10.1186/s12885-024-12112-0.